For the purpose of encouraging applications for approval of active substances that are suitable alternatives to approved active substances fulfilling one of the exclusion criteria listed in Article 5(1) of Regulation (EU) No 528/2012, it is appropriate to provide for reimbursement of the fee for such applications.
Recital 7, Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and char…
In forcesince 18 Jun 2013